April Hasna

April Hasna has a diverse work experience in the pharmaceutical industry. April started their career at Boehringer Ingelheim in 2014 as a Diabetes Sales Specialist and worked there until 2019. Following that, they joined Mallinckrodt Pharmaceuticals as an Acthar Specialist in the Immunology/Multiple Sclerosis department, where they worked until 2021. In 2021, April joined Biogen as a Sr. Territory Business Manager. Currently, they hold the position of Senior Area Business Manager at Acadia Pharmaceuticals Inc. where they are responsible for promoting and managing the sales of DAYBUE™, a treatment approved by the FDA for Rett syndrome.

April Hasna attended California State University, Fullerton from 1997 to 1999 and obtained a Bachelor of Arts (BA) degree in Communication and Media Studies. During the same period, they also attended the University of Tennessee, Knoxville, but it is not specified whether they completed a degree there. Their field of study at the University of Tennessee was Business Administration and Management, General.